Clinical Study
Utilization of Oncotype DX in an Inner City Population: Race or Place?
Table 1
Patient characteristics of women ODX tested versus not tested.
| | | Total | Test done (23%) | Test not done (77%) | P value |
| | Age (years), mean SD | | | | 0.1615 | | Race | | | | | | White | 110 (49%) | 34 (65%) | 76 (44%) | 0.0438 | | Black | 34 (15%) | 7 (13%) | 27 (16%) | | Hispanic | 71 (32%) | 10 (19%) | 61 (35%) | | Low income (<$15,000/yr) | 68 (33%) | 10 (20%) | 58 (37%) | 0.0246 | | Insurance | | | | | | Commercial | 126 (56%) | 36 (69%) | 90 (52%) | 0.0902 | | Medicare | 30 (13%) | 5 (10%) | 25 (14%) | | Medicaid/noninsured | 69 (31%) | 11 (21%) | 58 (34%) | | Hospital type | | | | | | Tertiary referral center | 188 (84%) | 51 (98%) | 137 (79%) | 0.0013 | | Municipal hospital | 37 (16%) | 1 (2%) | 36 (21%) | | Stage | | | | | | IB | 112 (50%) | 42 (81%) | 70 (40%) |
<0.0001 | | IIA | 81 (36%) | 8 (15%) | 73 (42%) | | IIB | 32 (14%) | 2 (4%) | 30 (17%) | | No positive nodes | 144 (64%) | 47 (90%) | 97 (56%) | <0.0001 | | After 2007 | 150 (67%) | 40 (77%) | 110 (64%) | 0.0736 |
|
|
